Monika Tomaszuk

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma

Anna Sowa‐Staszczak, Dorota Pach, Renata Mikołajczak et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 119 citations · Full text

Medicine, Endocrinology, Radiology +17

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

Anna Sowa‐Staszczak, Dorota Pach, Robert Chrzan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 109 citations · Full text

Medicine, Oncology, Surgery +11

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET

Dorota Pach, Anna Sowa‐Staszczak, Jolanta Kunikowska et al. · Radiotherapy and Oncology · 2011 · 43 citations

Medicine, Nuclear Medicine, Oncology +17

99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

Anna Sowa‐Staszczak, Małgorzata Trofimiuk–Müldner, Agnieszka Stefańska et al. · PLoS ONE · 2016 · 41 citations · Full text

Medicine, Endocrinology, Surgery +17

Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours.

Anna Sowa‐Staszczak, Dorota Pach, Jolanta Kunikowska et al. · PubMed · 2011 · 26 citations

Medicine, Oncology, Pharmacology +17